JungE, AlfonsoJ, MonyerH, et al.Neuronal signatures in cancer. Int J Cancer, 2020; 147(12):3281–3291; doi: 10.1002/ijc.33138
3.
WinklerF, VenkateshHS, AmitM, et al.Cancer neuroscience: State of the field, emerging directions. Cell, 2023; 186(8):1689–1707; doi: 10.1016/j.cell.2023.02.002
4.
DjamgozMBA, LevinM. Bioelectricity is the bridge where cancer meets neuroscience. Bioelectricity, 2021; 3(3):159–160; doi: 10.1089/bioe.2021.0024
5.
DjamgozMBA. Electrical excitability of cancer cells-CELEX model updated. Cancer Metastasis Rev, 2024; 43(4):1579–1591; doi: 10.1007/s10555-024-10195-6
6.
RibeiroM, ElghajijiA, FraserSP, et al.Human breast cancer cells demonstrate electrical excitability. Front Neurosci, 2020; 14:404; doi: 10.3389/fnins.2020.00404
7.
McCallumGA, ShiralkarJ, SuciuD, et al.Chronic neural activity recorded within breast tumors. Sci Rep, 2020; 10(1):14824; doi: 10.1038/s41598-020-71670-y
8.
HungTY, WuSN, HuangCW. Eslicarbazepine, a third-generation anti-seizure medication, inhibits INa but stimulates IK(M). Neurochem Int, 2025; 187:105990; doi: 10.1016/j.neuint.2025.105990
9.
QiuS, FraserSP, PiresW, et al.Anti-invasive effects of minoxidil on human breast cancer cells: Combination with ranolazine. Clin Exp Metastasis, 2022; 39(4):679–689; doi: 10.1007/s10585-022-10166-7
10.
AfsordehN, PournajafS, BayatH, et al.Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model. BMC Cancer, 2024; 24(1):1099; doi: 10.1186/s12885-024-12840-3
11.
LeslieTK, BrücknerL, ChawlaS, et al.Inhibitory effect of eslicarbazepine acetate and S-licarbazepine on Nav1.5 channels. Front Pharmacol, 2020; 11:555047; doi: 10.3389/fphar.2020.555047
12.
BrackenburyWJ, ChioniAM, DissJK, et al.The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat, 2007; 101(2):149–160; doi: 10.1007/s10549-006-9281-1
13.
LastraioliE, FraserSP, GuzelRM, et al.Neonatal Nav1.5 protein expression in human colorectal cancer: Immunohistochemical characterization and clinical evaluation. Cancers (Basel), 2021; 13(15):3832; doi: 10.3390/cancers13153832
14.
MonniL, KrausL, Dipper-WawraM, et al.In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy. Br J Pharmacol, 2022; 179(1):84–102; doi: 10.1111/bph.15689
15.
DjamgozMBA. Ranolazine: A potential anti-metastatic drug targeting voltage-gated sodium channels. Br J Cancer, 2024; 130(9):1415–1419; doi: 10.1038/s41416-024-02622-w
16.
EskandariN, DelisiD, O’NeilR, et al.Activation of Kv11.1 potassium channel suppresses non-small cell lung cancer growth by promoting c-Myc degradation. Commun Biol, 2025; 8(1):1615; doi: 10.1038/s42003-025-08917-9
